• Albrecht J. (2005) Astrocytes in ammonia neurotoxicity: a target, a mediator and a shield, in The Role of Glia in Neurotoxicity (Aschner M. and Costa L. G., eds), pp. 329342. CRC Press, Boca Raton.
  • Albrecht J. and Jones E. A. (1999) Hepatic encephalopathy: molecular mechanisms underlying the clinical syndrome. J. Neurol. Sci. 170, 138146.
  • Cekanaviciute E., Fathali N., Doyle K. P., Williams A. M., Han J. and Buckwalter M. S. (2014) Astrocytic transforming growth factor-beta signaling reduces subacute neuroinflammation after stroke in mice. Glia 62, 12271240.
  • Chan H., Hazell A. S., Desjardins P. and Butterworth R. F. (2000) Effects of ammonia on glutamate transporter (GLAST) protein and mRNA in cultured rat cortical astrocytes. Neurochem. Int. 37, 243248.
  • Christopherson K. S., Ullian E. M., Stokes C. C., Mullowney C. E., Hell J. W., Agah A., Lawler J., Mosher D. F., Bornstein P. and Barres B. A. (2005) Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis. Cell 120, 421433.
  • Garcia O., Torres M., Helguera P., Coskun P. and Busciglio J. (2010) A role for thrombospondin-1 deficits in astrocyte-mediated spine and synaptic pathology in Down's syndrome. PLoS ONE 5, e14200.
  • Jayakumar A. R., Liu M., Moriyama M., Ramakrishnan R., Forbush B., 3rd, Reddy P. V. and Norenberg M. D. (2008) Na-K-Cl Cotransporter-1 in the mechanism of ammonia-induced astrocyte swelling. J. Biol. Chem. 283, 3387433882.
  • Jayakumar A. R., Tong X. Y, Curtis K. M., Ruiz-Cordero R., Shamaladevi N., Abuzamel M., Johnstone J., Gaidosh G., Rama Rao K. V. and Norenberg M. D. (2014) Decreased astrocytic thrombospondin-1 secretion after chronic ammonia treatment reduces the level of synaptic proteins: in vitro and in vivo studies. J. Neurochem.
  • Liauw J., Hoang S., Choi M. et al. (2008) Thrombospondins 1 and 2 are necessary for synaptic plasticity and functional recovery after stroke. J. Cereb. Blood Flow Metab. 28, 17221732.
  • Norenberg M. D., Hugo Z., Neary J. T. and Roig-Cantesano A. (1997) The glial glutamate transporter in hyperammonemia and hepatic encephalopathy: relation to energy metabolism and glutamatergic neurotransmission. Glia 21, 124133.
  • Obara-Michlewska M., Pannicke T., Karl A., Bringmann A., Reichenbach A., Szeliga M., Hilgier W., Wrzosek A., Szewczyk A. and Albrecht J. (2011) Down-regulation of Kir4.1 in the cerebral cortex of rats with liver failure and in cultured astrocytes treated with glutamine: implications for astrocytic dysfunction in hepatic encephalopathy. J. Neurosci. Res. 89, 20182027.
  • Peterson C., Giguere J. -F., Cotman C. W. and Butterworth R. F. (1990) Selective loss of N-methyl-D-aspartate binding sites in rat brain following portacaval anastomosis. J. Neurochem. 55, 386390.
  • Prakash R. and Mullen K. D. (2010) Mechanisms, diagnosis and management of hepatic encephalopathy. Nat. Rev. Gastroenterol. Hepatol. 7, 515525.
  • Rama Rao K. V., Curtis K. M., Johnstone J. T. and Norenberg M. D. (2013) Amyloid-[beta] inhibits thrombospondin 1 release from cultured astrocytes: effects on synaptic protein expression. J. Neuropathol. Exp. Neurol. 72, 735744.
  • Rangroo Thrane V., Thrane A. S., Wang F. et al. (2013) Ammonia triggers neuronal disinhibition and seizures by impairing astrocyte potassium buffering. Nat. Med. 19, 16431648.
  • Saransaari P., Oja S. S., Borkowska H. D., Kostinaho J., Hilgier W. and Albrecht J. (1997) Effects of thioacetamide-induced hepatic failure on the N-methyl-D-aspartate receptor complex in the rat cerebral cortex, striatum and hippocampus: binding of different ligands and expression of receptor subunit mRNA's. Mol. Chem. Neuropathol. 32, 179194.
  • Sotil E. U., Gottstein J., Ayala E., Randolph C. and Blei A. T. (2009) Impact of preoperative overt hepatic encephalopathy on neurocognitive function after liver transplantation. Liver Transpl. 15, 184192.